|
Volumn 2, Issue 4, 1996, Pages 206-210
|
Immunomodulation with linomide: possible novel therapy for multiple sclerosis.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IMMUNOLOGICAL ADJUVANT;
QUINOLINOL DERIVATIVE;
ROQUINIMEX;
ADULT;
ALLERGIC ENCEPHALOMYELITIS;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE COURSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
FEMALE;
HUMAN;
LYMPHOCYTE;
MACROPHAGE;
MALE;
MIDDLE AGED;
MULTIPLE SCLEROSIS;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATHOLOGY;
PILOT STUDY;
ADJUVANTS, IMMUNOLOGIC;
ADULT;
DISEASE PROGRESSION;
DOUBLE-BLIND METHOD;
ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL;
FEMALE;
HUMANS;
HYDROXYQUINOLINES;
LYMPHOCYTES;
MACROPHAGES;
MAGNETIC RESONANCE IMAGING;
MALE;
MIDDLE AGED;
MULTIPLE SCLEROSIS;
PILOT PROJECTS;
|
EID: 0030275527
PISSN: 13524585
EISSN: None
Source Type: Journal
DOI: 10.1177/135245859600200407 Document Type: Article |
Times cited : (9)
|
References (0)
|